Use of an intravenous port catheter for the delivery of intrathecal morphine in a terminally ill cancer patient with pain

References

1. ↵
   1. Stearns LM,
   2. Abd-Elsayed A,
   3. Perruchoud C,
   4. Spencer R,
   5. Hammond K,
   6. Stromberg K,
   7. et al.

   (2020) Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry. Anesth Analg 130, 289–297.
2. ↵
   1. Alotaibi RM,
   2. Rezk HR,
   3. Juliana CI,
   4. Guure C

   (2018) Breast cancer mortality in Saudi Arabia: Modeling observed and unobserved factors. PLoS One 13, e0206148.
3. ↵
   1. World Health Organization

   (2007) Access to Controlled Medications Programme: Framework (World Health Organization, Geneva (CH)) Accessed January 2020. Available at: http://www.who.int/medicines/areas/quality_safety/Framework_ACMP_withcover.pdf.
4. ↵
   1. Al-Rowaili A,
   2. Al-aqeel SA,
   3. Al-Naim LS,
   4. Al-Diab AI

   (2009) Appropriateness of cancer pain management in Saudi teaching hospital. Gulf J Oncolog, 37–43.
5. ↵
   1. levy MH

   (1999) Pain control in patients with cancer. Oncology (Williston Park) 13, 9–14.
6. ↵
   1. Meier EA,
   2. Gallegos JV,
   3. Montross-Thomas LP,
   4. Depp CA,
   5. Irwin SA,
   6. Jeste DV

   (2016) Defining a good death (successful dying): Literature Review and a call for research and public dialogue. Am J Geriatr Psychiatry 24, 261–271.
7. ↵
   1. Bottros MM,
   2. Christo PJ

   (2014) Current perspectives on intrathecal drug delivery. J Pain Res 7, 615–626.
8. ↵
   1. Yaksh TL,
   2. Rudy TA

   (1976) Analgesia mediated by a direct spinal action of narcotics. Science 192, 1357–1358.
9. ↵
   1. Wang JK,
   2. Nauss LA,
   3. Viars P

   (1979) Pain relief by intrathecally applied morphine in man. Anesthesiology 50, 149–151.
10. ↵
    1. Lebeaux D,
    2. Fernández-Hidalgo N,
    3. Chauhan A,
    4. Lee S,
    5. Marc Ghigo J,
    6. Almirante B,
    7. et al.

    (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14, 146–159.